Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-16-001421
Filing Date
2016-09-02
Accepted
2016-09-02 11:40:33
Documents
1
Period of Report
2016-04-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3130
  Complete submission text file 0000904454-16-001421.txt   4511
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Issuer) CIK: 0001415684 (see all company filings)

EIN.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 460 ASPEN DRIVE PARK CITY UT 84098
Business Address
Jenkins Stacey Y (Reporting) CIK: 0001643822 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-53166 | Film No.: 161867626